» Authors » Adoracion Navarro-Torne

Adoracion Navarro-Torne

Explore the profile of Adoracion Navarro-Torne including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 83
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Navarro-Torne A, Anderson A, Panwar K, Ghys E, Benninghoff B, Weynants V, et al.
Vaccine . 2024 Aug; 42(24):126215. PMID: 39213982
Background: Bivalent human papillomavirus HPV16/18-AS04 vaccine (Cervarix, GSK) offers direct protection against HPV16/18. Results from randomised controlled trials showed cross protective effects and suggested that declines in some closely related...
3.
Wu Q, Qian M, Welby S, Guignard A, Rosillon D, Gopala K, et al.
Hum Vaccin Immunother . 2023 Dec; 19(3):2283912. PMID: 38038626
Following the approval of for the immunization of girls and women in China against high-risk human papillomavirus types 16 and 18, a non-interventional post-authorization safety study was performed. A multi-center...
4.
Navarro-Torne A, Curcio D, Moisi J, Jodar L
PLoS One . 2021 Sep; 16(9):e0258030. PMID: 34591924
Background: Streptococcus agalactiae or group B Streptococcus (GBS) has emerged as an important cause of invasive disease in adults, particularly among the elderly and those with underlying comorbidities. Traditionally, it...
5.
Navarro-Torne A, Montuori E, Kossyvaki V, Mendez C
Hum Vaccin Immunother . 2021 Jun; 17(10):3670-3686. PMID: 34106040
The aim was to summarize pneumococcal disease burden data among adults in Southern Europe and the potential impact of vaccines on epidemiology. Of 4779 identified studies, 272 were selected. Invasive...
6.
Navarro-Torne A, Hanrahan F, Kerstiens B, Aguar P, Matthiessen L
Emerg Infect Dis . 2019 Jan; 25(2). PMID: 30666948
Influenza virus infections are a major public health threat. Vaccination is available, but unpredictable antigenic changes in circulating strains require annual modification of seasonal influenza vaccines. Vaccine effectiveness has proven...
7.
Navarro-Torne A, Vidal M, Trzaska D, Passante L, Crisafulli A, Laang H, et al.
Eur Respir J . 2015 Sep; 46(5):1270-80. PMID: 26405284
No abstract available.
8.
Navarro-Torne A, Gomes Dias J, Hruba F, Lopalco P, Pastore-Celentano L, Gauci A
Emerg Infect Dis . 2015 Feb; 21(3):417-25. PMID: 25693604
We studied the possible association between patient age and sex, clinical presentation, Streptococcus pneumoniae serotype, antimicrobial resistance, and death in invasive pneumococcal disease cases reported by 17 European countries during...
9.
Munoz-Almagro C, Navarro-Torne A, Pallares R
Curr Infect Dis Rep . 2013 Feb; 15(2):184-90. PMID: 23381547
This review is based on published literature about some of the potential advantages and challenges of the second generation of pneumococcal conjugate vaccines, with special reference to 13-valent vaccine in...